SecProbe.io

CORRESP
1
filename1.htm

100 Park Avenue,
Suite 1500

New York, NY 10017

Tel 212.878.7900
Fax 212.692.0940

www.foxrothschild.com

Alison Newman

Direct Dial: 212-878-7997

Email Address: ANewman@Foxrothschild.com

June 13, 2014

U.S. Securities
and Exchange Commission

Division of
Corporation Finance

100 F Street,
N.E.

Washington,
DC 20549

 Attention: Mark P. Shuman

Ivan Griswold

Laura Veator

Stephen Krikorian

 Re: Medical Transcription Billing,
Corp.

Registration
Statement on Form S-1

Filed
on May 30, 2014

File
No. 333-192989

Ladies
and Gentlemen:

On
behalf of our client, Medical Transcription Billing, Corp. (“MTBC” or the “Company”), we
are responding to the comments of the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”)
contained in its letter dated June 10, 2014 (the “Comment Letter”), relating to the above referenced Registration
Statement on Form S-1 (the “Registration Statement”). In response to the comments set forth in the Comment
Letter, MTBC has revised the Registration Statement and is filing Amendment No. 4 to the Registration Statement with this response
letter. We are also providing by overnight mail for the Staff’s reference a copy of Amendment No. 4 to the Registration
Statement marked to show all changes from the Registration Statement filed on May 30, 2014.

In
this letter, we have recited the comments from the Staff in italicized, bold type and have followed each comment with the Company’s
response. Except as otherwise specifically indicated, page references herein correspond to the page of the revised draft of the
Registration Statement, as applicable.

U.S. Securities and Exchange Commission

June 13, 2014

Page 2

Notes to Consolidated
Financial Statements as of and for the Years Ended December 31, 2013 and 2012

13. Income Taxes,
page F-26

1.          We
note your response to prior comment 5 that the $41,714 of state tax expense for the year ended December 31, 2013 primarily arose
due to the true-up of New Jersey state net operating losses because the dividend exclusion is not an allowable deduction in computing
the New Jersey state net operating loss. However, we note that your disclosure indicates that for state tax purposes, the Company’s
Pakistan earnings generally are not taxed due to a subtraction modification available in most states. As a result, the Company
has reported cumulative losses at the state level for the last three years. Please clarify your disclosures so that they are consistent
with your response, and provide an explanation for the state tax expense.

The
Company advises the Staff that it has revised its disclosure on page F-26 as requested by the Staff, in the manner set forth
in the Company’s letter to the Commission dated June 11, 2014.

Notes
to Consolidated Financial Statements as of and for the Three Months Ended March 31, 2014

10.
Income Taxes

2.          We
note your response to prior comment 6. Tell us what your estimated annual effective tax rate is based on your current best estimate.
To the extent there is a material difference between this rate and the rate that you have used for the interim period, please
further clarify how a small change in your estimated ordinary income would produce a significant change in the effective tax rate.
In this regard, it does not appear that you have historically had significant permanent differences. Please also clarify the amount
of minimum taxes that may be due in certain jurisdictions.

We
refer the Staff to the Company’s response to this comment in its letter to the Commission dated June 11, 2014.

U.S. Securities and Exchange Commission

June 13, 2014

Page 3

Sincerely,

/s/ Alison
Newman

 cc: Mahmud Haq, Medical Transcription
Billing, Corp.

Bill Korn, Medical Transcription Billing, Corp.

Stephen Snyder, Medical Transcription Billing, Corp.

Mitchell Nussbaum, Loeb & Loeb LLP